Lonza to expand development services for mammalian products in Singapore
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Since its inception, the company has either acquired or taken a majority stake in five companies
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
Subscribe To Our Newsletter & Stay Updated